Nitrogen Mustard: a Promising Class of Anti-Cancer Chemotherapeutics – a Review
Biointerface Research in Applied Chemistry · 29.03.2022 · 13 (2) · 161
DOI: 10.33263/briac132.161 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biointerface Research in Applied Chemistry, online erschienen am 29.03.2022. Die Arbeit wurde bisher 10-mal zitiert (Crossref).
Abstract (Originalsprache)
The cancer tissue hypoxia regions are present with an acidic microenvironment that prevent the intake of various components like drugs, nutrients, and other metabolites, encouraging the resistance to various therapies. Chemotherapy, among all therapies, causes great off-target toxicity. Thus the focus of research is on the target drug delivery that ensures the efficacy, selectivity, and cytotoxicity within the tumor regions only. For this reason, many classes of chemotherapeutic drugs such as alkylating agents, antibiotics, antimetabolites, hormonal therapy, and other miscellaneous agents have been introduced. Although alkylating agents serve various sub-classes such as nitrosourea, nitrogen mustard, triazide, methanesulphonate, and ethylenimines, our review particularly focused on Nitrogen Mustard (NM). NM is one of the most widely used among all other classes since its high electrophilicity provides diversity in its reactivity and attachment to other synthetic and natural components.
Zitieren
APA
(2022). Nitrogen Mustard: a Promising Class of Anti-Cancer Chemotherapeutics – a Review. Biointerface Research in Applied Chemistry, 13(2), 161. https://doi.org/10.33263/briac132.161
Vancouver
Nitrogen Mustard: a Promising Class of Anti-Cancer Chemotherapeutics – a Review. Biointerface Research in Applied Chemistry. 2022;13(2):161. doi:10.33263/briac132.161
BibTeX
@article{euvimed2022,
title = {Nitrogen Mustard: a Promising Class of Anti-Cancer Chemotherapeutics – a Review},
journal = {Biointerface Research in Applied Chemistry},
year = {2022},
volume = {13},
number = {2},
pages = {161},
doi = {10.33263/briac132.161}
}
EUVIMED